MIR6871

Across TCGA pan-cancer cohorts, MIR6871 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MIR6871 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MIR6871 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6871 expression acts as an unfavorable survival marker, although some lineages such as PAAD and SKCM show a favorable association.

THCA, COAD, and KIRC are the cancer types where MIR6871 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	IV	0.290	0.856	<.001	87	view →
COAD	DFS	Tertile	All	0.309	0.569	.001	66	view →
KIRC	DFS	Quartile	II,III,IV	0.581	0.723	.005	50	view →
LGG	DFS	Tertile	All	0.283	0.436	<.001	39	view →
ACC	DFS	Tertile	All	0.262	0.671	.004	33	view →
CHOL	DFS	Tertile	II,III,IV	0.105	0.505	.012	30	view →
ESCA	OS	Median	IV	0.222	0.698	.006	30	view →
STAD	DFS	Quartile	II,III,IV	0.422	0.568	.009	29	view →
UVM	DFS	Tertile	All	0.248	0.803	<.001	27	view →
HNSC	OS	Tertile	III,IV	0.272	0.579	.006	27	view →
UCEC	DFS	Tertile	All	0.436	0.711	.004	20	view →
TGCT	OS	Tertile	II,III,IV	0.802	1.000	.040	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MIR6871–THCA (DFS)

Open the THCA breakdown →